UCB Showcases Key Rheumatology Data at ACR Convergence 2021
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF...
Stay updated with breaking news from Deep Learning Algorithm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF...
Share this article BRISBANE, Calif., Feb. 18, 2021 /PRNewswire/ -- Caption Health, a leading medical artificial intelligence (AI) company providing AI guidance and interpretation for ultrasound, today announced the publication of the study that was the basis for the February 2020 authorization of Caption Guidance™ through the FDA's De Novo pathway. The Caption AI platform, which includes Caption Guidance and Caption Interpretation™, is the first and only AI-guided medical imaging acquisition software to obtain FDA clearance, enabling a broad range of healthcare workers to perform cardiac...